1621534-30-2

Basic information

• Product Name: (1R,3aR,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-benzyl 1-amino-5a,5b,8,8,11a-pentamethyl-9-oxoicosahydro-1H-cyclopenta[a]chrysene-3a-carboxylate
• Synonyms: (1R,3aR,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-benzyl 1-amino-5a,5b,8,8,11a-pentamethyl-9-oxoicosahydro-1H-cyclopenta[a]chrysene-3a-carboxylate
• CAS NO: 1621534-30-2
• Molecular Weight: 519.768
• Mol File: 1621534-30-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (1R,3aR,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-benzyl 1-amino-5a,5b,8,8,11a-pentamethyl-9-oxoicosahydro-1H-cyclopenta[a]chrysene-3a-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,3aR,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-benzyl 1-amino-5a,5b,8,8,11a-pentamethyl-9-oxoicosahydro-1H-cyclopenta[a]chrysene-3a-carboxylate(1621534-30-2)
• EPA Substance Registry System: (1R,3aR,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-benzyl 1-amino-5a,5b,8,8,11a-pentamethyl-9-oxoicosahydro-1H-cyclopenta[a]chrysene-3a-carboxylate(1621534-30-2)

Safety Data

• Hazardous Substances Data: 1621534-30-2(Hazardous Substances Data)

Upstream product

• 6060-06-6 platanic acid 
• 1472003-50-1 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-benzyl 1-acetyl-9-hydroxy-5a,5b,8,8,11a-pentamethylicosahydro-1H-cyclopenta[a]chrysene-3a-carboxylate 
• 1621534-27-7 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-3a-((benzyloxy)carbonyl)-9-hydroxy-5a,5b,8,8,11a-pentamethylicosahydro-1H-cyclopenta[a]chrysene-1-carboxylic acid 
• 1621534-28-8 (1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-benzyl 1-((azidocarbonyl)amino)-9-hydroxy-5a,5b,8,8,11a-pentamethylicosahydro-1H-cyclopenta[a]chrysene-3a-carboxylate 
• 1621534-29-9 (1R,3aR,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-benzyl 1-((azidocarbonyl)amino)-5a,5b,8,8,11a-pentamethyl-9-oxoicosahydro-1H-cyclopenta[a]chrysene-3a-carboxylate 
• 100-39-0 benzyl bromide 

Downstream Products

• 1621534-31-3 (1R,3aR,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-benzyl 1-((tert-butoxycarbonyl)amino)-5a,5b,8,8,11a-pentamethyl-9-oxoicosahydro-1H-cyclopenta[a]chrysene-3a-carboxylate 

Relevant articles and documents

C-19 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, C-19 modified triterpenoids that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formulas I and II: These compounds are useful for the treatment of HIV and AIDS.